152 related articles for article (PubMed ID: 24443104)
21. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
22. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
[TBL] [Abstract][Full Text] [Related]
24. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics of fibrolamellar hepatocellular carcinoma.
Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Törzsök P; Kovalszky I; Barbai T; Rásó E; Lotz G; Schaff Z; Kiss A
Pathol Oncol Res; 2013 Jan; 19(1):63-70. PubMed ID: 22872444
[TBL] [Abstract][Full Text] [Related]
26. Fibrolamellar hepatocellular carcinoma in an infant and literature review.
Cruz O; Laguna A; Vancells M; Krauel L; Medina M; Mora J
J Pediatr Hematol Oncol; 2008 Dec; 30(12):968-71. PubMed ID: 19131794
[TBL] [Abstract][Full Text] [Related]
27. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
Malouf GG; Brugières L; Le Deley MC; Faivre S; Fabre M; Paradis V; Aerts I; Le Tourneau C; Dreyer C; Branchereau S; Belghiti J; Raymond E
Cancer; 2012 Oct; 118(20):4981-90. PubMed ID: 22415897
[TBL] [Abstract][Full Text] [Related]
28. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
29. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Sárosi I; Kiss A; Schaff Z; Lapis K
Acta Morphol Hung; 1991; 39(4):321-31. PubMed ID: 1668901
[TBL] [Abstract][Full Text] [Related]
31. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Sárosi I; Kiss A; Schaff Z; Lapis K
Acta Microbiol Hung; 1991; 39(4):321-31. PubMed ID: 1668900
[TBL] [Abstract][Full Text] [Related]
32. Genomic homogeneity in fibrolamellar carcinomas.
Sirivatanauksorn Y; Sirivatanauksorn V; Lemoine NR; Williamson RC; Davidson BR
Gut; 2001 Jul; 49(1):82-6. PubMed ID: 11413114
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
34. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
36. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
37. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
38. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
Ward SC; Waxman S
Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
[TBL] [Abstract][Full Text] [Related]
39. Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue.
Nagai K; Kohno K; Chiba M; Pak S; Murata S; Fukunaga K; Kobayashi A; Yasue H; Ohkohchi N
Int J Oncol; 2012 Jun; 40(6):1813-20. PubMed ID: 22366890
[TBL] [Abstract][Full Text] [Related]
40. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
